Clearpoint Neuro Inc Revenue Growth Rates (CLPT), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Clearpoint Neuro Inc   (NASDAQ: CLPT)
 

CLPT's Revenue Growth by Quarter and Year

Clearpoint Neuro Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CLPT Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 10.88
1st Quarter March 12.13
FY 23.01

CLPTs Annual Revenue
Clearpoint Neuro Inc 's Revenue in the fiscal year 2025 $ 36.97 millions
Clearpoint Neuro Inc 's Revenue in the fiscal year 2024 $ 31.39 millions
Clearpoint Neuro Inc 's Revenue in the fiscal year 2023 $ 23.96 millions
Clearpoint Neuro Inc 's Revenue in the fiscal year 2022 $ 20.55 millions
Clearpoint Neuro Inc 's Revenue in the fiscal year 2021 $ 16.30 millions




CLPT Revenue second quarter 2026 Y/Y Growth Comment
Clearpoint Neuro Inc reported Revenue increase of 18% year on year in the second quarter 2026, to $ 10.88 millions, this is lower than Clearpoint Neuro Inc 's recent average Revenue increase of 19.22%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 115 other companies have achieved higher Revenue growth. While Clearpoint Neuro Inc ' s Revenue growth of 18% ranks overall at the positon no. 2159 in the second quarter 2026.


CLPT Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 33.98 % 14.1 % 31.72 %
3rd Quarter September - 9.11 % 40.97 % 11.84 %
2nd Quarter June 18 % 17.3 % 32.1 % 14.42 %
1st Quarter March 42.87 % 11.13 % 40.7 % 7.95 %
FY   - 17.81 % 31.06 % -

Financial Statements
Clearpoint Neuro Inc 's second quarter 2026 Revenue $ 10.88 millions CLPT's Income Statement
Clearpoint Neuro Inc 's second quarter 2025 Revenue $ 9.22 millions Quarterly CLPT's Income Statement


CLPT Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 17.49 % -4.31 % 18.23 %
3rd Quarter September - -3.9 % 3.31 % -3.19 %
2nd Quarter June -10.31 % 8.6 % 2.88 % 9.58 %
1st Quarter March 16.52 % 9.27 % 12.19 % 5.03 %
FY (Year on Year)   - 17.81 % 31.06 % -


Back to CLPT Growth rate Comparisons >> Back to CLPT Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #116
Healthcare Sector #321
Overall #2159

Revenue Y/Y Growth Statistics
High Average Low
53.27 % 19.22 % -34.69 %
(Jun 30 2016)   (Mar 31 2014)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #116
Healthcare Sector #321
Overall #2159
Revenue Y/Y Growth Statistics
High Average Low
53.27 % 19.22 % -34.69 %
(Jun 30 2016)   (Mar 31 2014)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Clearpoint Neuro Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
64.89 % 7.24 % -55.51 %
(Sep 30 2013)  


CLPT's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Clearpoint Neuro Inc disclosed drop in Revenue from the first quarter by -10.31% to $ 10.88 millions, from $ 12.13 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 116 other companies have achieved higher Revenue quarter on quarter growth. While Clearpoint Neuro Inc 's Revenue growth quarter on quarter, overall rank is 2877.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #117
Healthcare Sector #367
Overall #2877
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #117
Healthcare Sector #367
Overall #2877
Revenue Q/Q Growth Statistics
High Average Low
64.89 % 7.24 % -55.51 %
(Sep 30 2013)  


CLPT's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Clearpoint Neuro Inc disclosed drop in Revenue from the first quarter by -10.31% to $ 10.88 millions, from $ 12.13 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 116 other companies have achieved higher Revenue quarter on quarter growth. While Clearpoint Neuro Inc 's Revenue growth quarter on quarter, overall rank is 2877.


Clearpoint Neuro Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 42.28 $ 40.61 $ 36.97 $ 34.33 $ 33.59
Y / Y Revenue Growth (TTM) 25.86 % 25.99 % 17.78 % 12.83 % 19.68 %
Year on Year Revenue Growth Overall Ranking # 880 # 571 # 317 # 313 # 339
Seqeuential Revenue Change (TTM) 4.1 % 9.85 % 7.69 % 2.2 % 4.21 %
Seq. Revenue Growth (TTM) Overall Ranking # 2170 # 1931 # 1703 # 1235 # 1189


Cumulative Revenue growth Comment
Assuming the Clearpoint Neuro Inc 's fiscal year would have ended in Jun 30 2026, Clearpoint Neuro Inc would have reprted above average annual Revenue rise of 25.86% year on year, of $ 42 millions.
This marks a slow-down of the companys growth trends and from the 25.99% improvement in Mar 31 2026.

In the Healthcare sector 178 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 571 to 880.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 179
Overall # 880

Revenue TTM Y/Y Growth Statistics
High Average Low
53.27 %
 19.22 %
-34.69 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 321
S&P 500 # 2170
Cumulative Revenue growth Comment
Assuming the Clearpoint Neuro Inc 's fiscal year would have ended in Jun 30 2026, Clearpoint Neuro Inc would have reprted above average annual Revenue rise of 25.86% year on year, of $ 42 millions.
This marks a slow-down of the companys growth trends and from the 25.99% improvement in Mar 31 2026.

In the Healthcare sector 178 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 571 to 880.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 179
Overall # 880

Revenue TTM Y/Y Growth Statistics
High Average Low
53.27 %
19.22 %
-34.69 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 321
S&P 500 # 2170




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CLPT's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue improvement for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Aclarion Inc 30.48%$ 30.483 millions
Harmony Biosciences Holdings inc 30.42%$ 30.421 millions
Personalis Inc 29.96%$ 29.960 millions
Beone Medicines Ltd 29.69%$ 29.693 millions
Capsovision Inc 29.60%$ 29.598 millions
Intuitive Surgical Inc 29.27%$ 29.272 millions
Xeris Biopharma Holdings Inc 28.74%$ 28.741 millions
Ultragenyx Pharmaceutical Inc 28.53%$ 28.532 millions
Innoviva Inc 28.39%$ 28.391 millions
Electrocore Inc 28.03%$ 28.031 millions
Lightwave Logic Inc 27.91%$ 27.909 millions
American Shared Hospital Services27.15%$ 27.149 millions
Protalix Biotherapeutics inc 27.07%$ 27.066 millions
Alkermes Plc 26.97%$ 26.968 millions
Lucid Diagnostics Inc 26.74%$ 26.741 millions
Lifestance Health Group Inc 26.08%$ 26.076 millions
Ani Pharmaceuticals Inc25.87%$ 25.866 millions
Sight Sciences Inc 25.83%$ 25.830 millions
Grail Inc 25.72%$ 25.723 millions
Fortress Biotech Inc 25.66%$ 25.658 millions
Apyx Medical Corp25.27%$ 25.273 millions
Radnet Inc 24.99%$ 24.986 millions
Precipio inc 24.18%$ 24.178 millions
Krystal Biotech Inc 24.14%$ 24.135 millions
Viemed Healthcare Inc 23.85%$ 23.853 millions
Ardelyx inc 23.77%$ 23.771 millions
Insulet Corporation23.51%$ 23.509 millions
Veracyte Inc 23.45%$ 23.448 millions
Journey Medical Corp23.33%$ 23.326 millions
Twist Bioscience Corporation23.24%$ 23.235 millions


About Clearpoint Neuro Inc Revenue Growth Rates (CLPT), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Clearpoint Neuro Inc (CIK 1285550).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-330842
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Clearpoint Neuro Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.